Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines

Intranasal vaccination aims to elicit mucosal immunity in the respiratory tract to better protect against respiratory infections (e.g., SARS-CoV-2 and influenza). Most vaccines, including recent COVID-19 mRNA lipid nanoparticles (LNPs), are optimized for intramuscular (i.m.) administration and typic...

Full description

Saved in:
Bibliographic Details
Main Authors: Mai N. Vu, Devaki Pilapitiya, Andrew Kelly, Marios Koutsakos, Stephen J. Kent, Jennifer A. Juno, Hyon-Xhi Tan, Adam K. Wheatley
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253125001015
Tags: Add Tag
No Tags, Be the first to tag this record!